⚠️BREAKING: *NOVO NORDISK SPIKES TO RECORD HIGH AFTER STUDY SHOWS OBESITY DRUG WEGOVY CUT THE RISK OF HEART ATTACK BY 20% $NVO
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: Only post material that’s relevant to the topic being discussed. Avoid profanity, slander or personal attacks
directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% - trial dataNovo Nordisk's obesity drug Wegovy has shown a clear medical benefit, reducing the risk of heart disease by 20% according to a large late-stage study. The positive results have boosted the Danish drugmaker's hopes of repositioning Wegovy as more than just a lifestyle drug.
Weiterlesen »
Weight-Loss Drug Wegovy Lowers Major Heart Disease Risk By 20% According To Trial Data—Novo Nordisk Shares SurgeNovo Nordisk's shares rose by more than 16% on Tuesday, as the results of the trial exceeded investor expectations. The weight-loss drug Wegovy lowers the risk of 'adverse cardiovascular events' by 20%, according to data from a major trial shared by the drug's maker Novo Nordisk Tuesday, causing the company's shares to surge.
Weiterlesen »
Psychiatrists Prescribe Wegovy for Medication-Induced Weight GainPsychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used to treat mental disorders, such as schizophrenia or bipolar disorder.
Weiterlesen »
3 Reasons Why Shiba Inu (SHIB) Saw Massive 20% BreakthroughWith imminent launch of Shibarium, oversold market and investor confidence in face of scams, Shiba Inu (SHIB) saw significant 20% surge
Weiterlesen »
Monthly costs for homebuyers rise nearly 20%The average rate on 30-year fixed mortgage rose to 6.9% this week.
Weiterlesen »